Epigenetics provides a potential explanation for how environmental factors modify the risk for common diseases among individuals. Interindividual variation in DNA methylation and epigenetic regulation has been reported at specific genomic regions including transposable elements, genomically imprinted genes and the 'inactive' X chromosomes in females. We currently have a very poor understanding of the factors that contribute to interindividual epigenetic variation. In particular, it is important to understand when during the life cycle epigenetic variation arises, why epigenetic regulation varies among individuals, and whether epigenetic interindividuality affects susceptibility to diet-related chronic disease. In this review we will summarize current progress toward answering these questions.
Introduction
In recent decades many people have changed their lifestyles and nutritional habits in the interest of personal health. Whereas general nutrition recommendations like eating a varied diet and maintaining a healthy weight are probably universally beneficial, there is growing interest in tailoring nutrition recommendations to match individual metabolic characteristics. The nascent field of nutrigenomics is based on the assertion that responses to nutrition are dependent on each individual's genotype [1] . Herein we propose that epigenetic interindividuality should also be considered. Just as genetic variation affects nutrient metabolism, so too can epigenetic variation, and recent studies have documented myriad epigenetic differences among individuals. Important questions, however, remain unanswered: When during the life cycle does epigenetic variation arise? What are the factors that contribute to interindividual epigenetic variation? Does epigenetic interindividuality affect susceptibility to diet-related chronic disease? In this review we will summarize current progress toward answering these questions.
Epigenetic Gene Regulation
Epigenetics is the study of mitotically heritable changes in gene expression potential that occur without changing the DNA sequence [2] . Epigenetic regulation enables the developmental acquisition and lifelong maintenance of tissue-specific gene expression, despite continuous cellular turnover and DNA replication. Epigenetic mechanisms include methylation of CpG dinucleotides in DNA, autoregulatory DNA-binding proteins, and various modifications to the histone proteins that package DNA in nuclear chromatin [3] .
DNA methylation of cytosine residues within CpG dinucleotides is one of the best characterized epigenetic modifications. DNA methylation is the most stable epigenetic mark, and is often correlated with transcriptional activity [2] . Histone modifications have attracted increasing attention as important epigenetic marks. Their dynamic nature, however, coupled with the lack of a known mechanism for their perpetuation through mitosis, have recently led some leaders in the field to question whether histone modifications are truly epigenetic [4] . A relatively underexplored field is the role of autoregulatory DNA-binding proteins in the maintenance of epigenotype. For these reasons, the bulk of this review focuses on DNA methylation.
DNA methylation is critical for the regulation of embryonic development, cellular differentiation, X chromosome inactivation in females, suppression of transposable elements, and genomic imprinting [2] . The methylation pattern in a specific genomic locus affects gene transcription via direct or indirect interaction with DNA-binding proteins.
Interindividual Variation in Epigenotype
In addition to genotypic variation, epigenetic differences can contribute to stable phenotypic differences among individuals, such as metabolic variation, susceptibility to chronic disease, etc. [5] . Further, the incomplete penetrance of susceptibility genes and variation in phenotype (severity of disease) in genetically predisposed individuals may in part be explained by differences in epigenetic regulation [5] . We currently have a very poor understanding of the factors that contribute to interindividual epigenetic variation. Nonetheless, recent studies have documented substantial interindividual epigenetic variation in humans.
Dramatic interindividual variation in DNA methylation has been reported at specific transposable elements, viral-derived elements scattered throughout the genome [6] . This variation is not inconsequential; transposons, which Gomes/Waterland comprise roughly 45% of the genome, are found in about 4% of human genes [7] . Alu elements are short retrotranposons present at over a million copies in the human genome. Investigating the CpG methylation of 19 specific members of Alu sub-families in human DNA isolated from whole blood, Sandovici et al. [8] found significant interindividual variation in the level of methylation among 48 three-generation families. Interindividual epigenetic variation at Alu elements in the human genome was later confirmed in an epigenomic analysis [9] .
Animal models corroborate that specific transposable elements potentiate interindividual epigenetic differences among mammals. Two of the best characterized examples are the agouti viable yellow (A vy ) and the axin fused (Axin Fu ) mice. The murine A vy mutation resulted from transposition of an IAP retrotransposon upstream of the agouti gene, which normally regulates the production of yellow pigment in fur. The IAP contains a promoter that drives ectopic agouti expression and variation in CpG methylation of the A vy IAP, causing dramatic variation in coat color and other phenotypes among genetically identical A vy /a mice [10] . Similarly, the Axin Fu mutation resulted from transposition of an IAP into intron 6 of the Axin gene, which normally regulates anterior-posterior axial patterning during development. The Axin Fu IAP induces a downstream cryptic promoter which drives the expression of a biologically active 3Ј truncated transcript of Axin, causing a kinky tail phenotype [11] . Hypermethylation at Axin Fu silences expression from the cryptic promoter, preventing tail kinks.
These vividly illustrative mouse models show that even among genetically identical individuals, dramatic variation in phenotype can occur due to epigenetic variation at specific transposable elements. Rakyan et al. [12] proposed the term 'metastable epialleles' to describe genomic regions at which epigenotype is established probabilistically during development but then maintained stably throughout life. We envision that metastable epialleles likely exist in the human genome, affecting individual susceptibility not to yellow coats or kinky tails, but rather to various chronic diseases.
The human epigenome project is an effort to identify, catalog and interpret genome-wide DNA methylation profiles of all human genes in all major tissues [13] . The pilot project analyzed CpG methylation across the entire human major histocompatibility locus on chromosome 6 in several human tissues from different individuals. Over 100 gene regions displayed a difference of greater than 50% between the lowest and highest methylation values in different individuals [13] . For example, both the CYP21A2 gene and the gene encoding tumor necrosis factor showed marked interindividual variation ( fig. 1) . Following up on the success of the human epigenome pilot project, a larger study profiled methylation across most of human chromosomes 6, 20, and 22 [14] . Unfortunately, however, DNA from multiple individuals was pooled for each 'sample' characterized in that study, preventing the analysis of interindividual epigenetic variation. Individual Epigenetic Variation: When, Why, and So What?
Interindividual variation in humans has also been found at genomically imprinted genes. Genomic imprinting is an epigenetic phenomenon whereby certain genes are expressed preferentially from either the maternally or paternally inherited allele [15] . At the 11p15.5 human chromosome region, methylation at the paternally inherited allele of the H19 differentially methylated region (H19DMR) contributes to the regulation of monoallelic expression of both the insulin-like growth factor-2 (IGF2) and H19 genes. Variation of both allelic expression of IGF2 and methylation at the H19 DMR has been reported. For example, multiple studies on distinct human populations [16, 17] have found appreciable bi-allelic expression of IGF2 in about 10% of normal adults. Importantly, this IGF2 'loss of imprinting' appears to increase susceptibility to colon cancer [17] .
Interindividual variation in humans has also been reported in the epigenetic control of X inactivation [18] . Within each cell, most genes on one of each woman's two X chromosomes are silenced to achieve dosage compensation. However, about 10% of X-linked genes show variable patterns of inactivation and are expressed to different extents from the 'inactive' X chromosome ( fig. 2 ) comprising an additional source of epigenetic heterogeneity specific to females [18] .
Studies on monozygous (MZ) twins provide knowledge about both the occurrence and biological consequences of epigenetic variation. Although MZ twins are genetically identical, they are often discordant for various diseases such as schizophrenia and bipolar disorder [5] . Interindividual variation in epigenetic marks is a potential candidate to explain the discordances among MZ twins [5] . For example, in MZ twin pairs discordant for BeckwithWiedemann syndrome (BWS), a congenital disorder caused by abnormal imprinting at the 11p15.5 chromosomal region, Weksberg et al. [19] showed that only the affected members display abnormal methylation of KvDMR, the CpG island upstream of the imprinted KCNQ1OT1 gene.
When Do Epigenetic Differences among Individuals Arise?
During embryogenesis, epigenetic reprogramming results in the establishment of diverse patterns of gene expression that characterize the differentiated state of diverse cell and tissue types [20] . Increasingly, data are indicating that this epigenetic reprogramming is not limited to early embryonic development, but continues throughout fetal development and even into early postnatal life. Given that developmental establishment of epigenotype can be influenced by environmental stimuli such as nutrition [21] , it is important to determine the critical developmental periods when interindividual variation in epigenetic regulation is first established in humans.
In an extensive epigenomic analysis of MZ twins, Fraga et al. [9] concluded that epigenetic differences among MZ twins are not present during the early years of life, but rather arise in older MZ twins, related to environmental differences and epigenetic changes accumulated with aging. This conclusion, however, was based upon only two pairs of 3-year-old twins! A recent study [14] involving methylation analysis at human chromosomes 6, 20 and 22 in several tissues from two age groups of healthy individuals (one group having a mean age of 26 years and the second 68 years) did not find a significant overall effect of age, in apparent contradiction to the conclusion of Fraga et al. [9] .
The data from Weksberg et al. [19] showing divergent methylation patterns at KCNQ1OT1 in MZ twins discordant for BWS clearly indicates that interindividual epigenetic variation can be established very early in embryonic development. Similarly, Oates et al. [22] reported that discordances for methylation pattern at the promoter region of the AXIN1 gene are associated with discordances for caudal duplication anomalies in MZ twins aged 7 months.
Data from mouse models indicate that methylation profiles are dynamic and vary during prenatal and/or postnatal life. For example, Weaver et al. [23] documented remarkable developmental changes in methylation at specific CpG sites in the glucocorticoid receptor promoter in the rat hippocampus, during the first few days of postnatal life. Moreover, the level of maternal caregiving during this period permanently changed offspring physiology and behavior by affecting this developmental process.
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In addition to the prenatal and early postnatal periods, changes in DNA methylation at specific loci do correlate with age. For example, in human colonic mucosa, aberrant hypermethylation of the estrogen receptor gene increases linearly with age [24] . Analogously, in a study of nutritional effects on epigenetic changes in the post-weaning period, it was shown that developmental changes in allelic methylation at the mouse Igf2 DMR2 in kidney continue into adulthood [25] .
Overall, the data indicate that epigenetic differences among individuals can arise at diverse periods throughout life. Unlike the gradual changes that accumulate with aging, the rapid changes in epigenetic regulation that occur during prenatal and early postnatal development present brief periods during which nutrition and other environmental exposures may wield relatively powerful influence.
What Are the Sources of Interindividual Epigenetic Variation?
Potential sources of interindividual epigenetic variation include environmental factors, genetic inheritance, epigenetic inheritance, and stochastic (random) variation [26] .
Among environmental factors, nutrition has been shown to affect the development of epigenotype. The source of one carbon units for biological methylation reactions is S-adenosylmethionine. S-Adenosylmethionine levels are dependent on diet since mammals cannot synthesize sources of one-carbon units such as methionine and choline, or critical cofactors for methyl metabolism such as folic acid and vitamin B 12 . An unbalance (excess or deficiency) of these critical nutrients may alter the supply of methyl groups [21] .
The first direct evidence that maternal nutrition can affect offspring epigenotype was obtained by studies in mouse models. Nutritionally induced changes in the coat color of A vy /a mice were demonstrated to be consequent to an increased methylation at the A vy locus [27] . Additionally, dietary methyl donor deficiency during the post-weaning period causes persistent changes in the allelic expression of Igf2 in mice [25] , showing that the influence of nutrition on epigenetic development is not limited to the prenatal period.
The artificial environment to which the early embryo is exposed during in vitro fertilization might also result in epigenetic defects, and genomically imprinted genes might be especially susceptible [28] . Indeed, a recent study [29] showed aberrant DNA methylation and histone modifications at the Igf2/H19 imprinted domain in embryonic stem cells derived from in vitro fertilization. The association between assisted reproductive technologies and imprinting alterations in humans provides a foreboding corroboration of the results from mouse studies. Epidemiological studies show a 4-to 9-fold increased risk for BWS in children conceived by assisted reproductive technologies compared to those naturally conceived [30] .
Alcohol consumption may also induce epigenetic alterations. Alcohol has an antagonistic effect on folate methyl group metabolism and can negatively affect folate levels, and the folate perturbation affects DNA methylation and DNA synthesis. It was shown in rats that chronic alcohol consumption induces hypomethylation in genomic DNA [31] .
Genetic variation among individuals can also contribute to epigenetic variation. Recently, Heijmans et al. [32] investigated the relative contribution of heritable influences versus environmental and stochastic factors in determining DNA methylation at the IGF2/H19 imprinted domain in 196 adolescent and 176 middle-aged twins. By assessing epigenetic similarity among MZ and dizygotic twin pairs, they estimated heritability of H19 and IGF2 methylation. Their data indicate that heritable processes explain most of the variation in epigenotype at the imprinted locus [32] . Polymorphisms in genes affecting one carbon metabolism may influence the establishment of methylation marks and the individual predisposition to epigenetic diseases. Methylenetetrahydrofolate reductase (MTHFR) reduces 5,10-methylenetetrahydrofolate (methylene-THF) to 5-methyl-THF, a fungible methyl donor. A common polymorphism (C677T) in the MTHFR gene reduces enzyme activity and is associated with DNA hypomethylation [33] .
Lastly, although it has long been assumed that the epigenetic slate is wiped clean in the embryo shortly after fertilization [34] , transgenerational inheritance of epigenetic marks does sometimes occur in mammals [35] . Recent studies have suggested epigenetic inheritance of germline epimutation at the promoter region of the DNA repair genes MLH1 and MSH2 in individuals with a familial history of cancer [36, 37] . This is an extremely difficult area of study in humans, however, as it may be impossible to distinguish epigenetic inheritance from transgenerational recapitulation of epigenotype associated with genetic inheritance [38] .
In addition to environment, genetic and epigenetic inheritance, stochastic processes clearly contribute to individual variation in epigenotype [26] . The many diverse sources of interindividual epigenetic variation will complicate studies aimed at understanding the role of diet in determining epigenotype.
So What? Epigenetics and Human Disease
It is clear that epigenetic dysregulation causes developmental diseases and cancer [39] . The role of epigenetics in the pathogenesis of chronic dietrelated diseases such as obesity, cardiovascular disease, and type-2 diabetes, although of major interest [26] , is not yet clear. Any disease that can have a genetic basis, however, can equally likely have an epigenetic basis. Studies are currently underway to elucidate epigenetic mechanisms that contribute to the pathogenesis of common diseases, both in animal models and in human studies, for example in MZ twins.
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Conclusion
Consideration of interindividual epigenetic variation adds an entirely new level of complexity to the field of nutrigenomics. Whereas genetic variation can influence nutritional requirements, epigenetic variation can both influence nutritional requirements and be induced by nutritional stimuli during critical developmental periods. Moreover, the interaction between epigenetics and nutrition is likely to be affected by genetics. If, as anticipated, epigenetic variation plays an important role in the pathogenesis of diet-related chronic diseases, 'personalized nutrition' may merit especially important consideration during the prenatal and early postnatal periods when nutrition can wield a lasting impact on epigenotype.
Discussion
Dr. Lagercrantz: Can you say anything more about critical windows? Are they due to epigenetic mechanisms or are there special critical windows for epigenetic mechanisms? Is demethylation also important for epigenetic mechanisms?
Dr. Waterland: In terms of the critical windows, certainly various critical windows may be associated with specific developmental periods during which epigenetic mechanisms are being established. But I would like to stress that epigenetic mechanisms are not the only mechanisms that can lead to critical windows of development. For example, yesterday we discussed the hypothalamic development studies of Bouret et al. [1] . I think that work provides a very nice example where, in the mouse at least, there is a postnatal period during which hypothalamic innervation must occur. If it doesn't occur properly during this specific period, the animal is left with a permanent change in its ability to maintain energy homeostasis. So, although people increasingly seem to equate developmental plasticity with epigenetics, that is not appropriate; epigenetic mechanisms are just one potential class of mechanisms that can lead to this type of developmental plasticity. Regarding demethylation, that is one of the things we looked at in our microarray studies and showed that in the postnatal liver there were not only increases in methylation but also genes undergoing demethylation. When we looked at the temporal relationships between methylation and expression, in every case the transcriptional changes preceded methylation changes. So in the case of hypomethylation it appeared that transcription could override methylation and lead to a gene activation, and this activation subsequently led to hypomethylation. I am certainly not saying DNA methylation is not important, but rather that it probably serves to maintain transcriptionally active or inactive states.
Dr. Gluckman: About tissue specificity, you mentioned that it is a very important part of the story. For example, I showed yesterday and in our paradigm, fat and muscle can be seen to move in totally different directions under leptin induction, with PPAR␣ going up with leptin in one and demethylated in the other. So I think that the confusion in experiments is going to be very much driven by the problems of what tissue under what circumstance to look at. Even within tissues I suspect that one needs to look at individual cell types, which is going to make matters even more difficult, which is going to come down to the issues of how we look at individual cells and the methylation patterns in individual cells and whether we can actually use amplification techniques accurately. How do you feel about the use of amplification technology for single cell methylation analysis?
Dr. Waterland: As far as I know that is currently not possible because once the DNA is amplified, all the methylation information is lost. So either some type of methylation-sensitive enzyme digest or bisulfate modification must be done before amplification. As far as starting with DNA from one cell as a template, I think theoretically that may be possible but the tools are certainly not yet available.
Dr. Gluckman: If we just use the example of Weaver et al. [2] , just to make the point, how do you think that so much specificity is given on these mechanisms? Weaver's model, your model, our model, all are very gross stimuli whether leptin or your cocktail of methylation donors are given, or whether grooming experiments are done, and yet it all comes down to very few CpG islands, and indeed within one gene in Weaver's case where the 5Ј is affected and the 3Ј isn't. There is a lot of complexity and we all just say it must be small RNAs or something. Do you have a view on how that specificity of CpG island control is so precisely regulated?
Dr. Waterland: We really don't know how these various environmental stimuli are altering methylation. Even in our mouse studies, in which we are feeding a diet that provides more methyl donors and should lead to hypermethylation by 'mass action', is Individual Epigenetic Variation: When, Why, and So What?
perhaps not so simple. It may be that the environmental stimuli are inducing transcriptional changes which are then causing secondary changes in methylation. That is very consistent with the results of the study by Weaver et al. [2] in which the one CG site that is affected happens to be within a key transcription factor-binding site.
Dr. Gluckman: In the work we have been doing with Mark Hanson, we found one of the genes that most consistently regulated itself by methylation is Dnmt1, which is one of the key enzymes involved in actual methylation. So it does raise the issue of a hierarchy of control where methylation itself has been regulated; there are epigenetic changes in the enzymes actually regulating methylation. While we understand a lot about methylation, we don't actually understand very much about the demethylation pathways. What is the mechanism, because I don't think the demethylase has been unequivocally demonstrated?
Dr. Waterland: That is correct. Several years ago Bhattacharya et al. [3] reportedly identified the demethylase activity, but those results have not been corroborated. In our studies of postnatal hepatic development, when rapid DNA replication is occurring and methylation can be lost passively, demethylation appears to always follow transcriptional activation of a gene. Again, I don't mean to take away from the importance of DNA methylation because I think it serves a critical stabilizing role in the differentiation process.
Dr. Berry: There are a few rare patients with hereditary defects in methionine synthesis or adenosylmethionine production, and I believe there is at least one report. Have you performed a genome-wide analysis to see whether the methylation defects are consistent with your hypothesis? Some patients with a complete absence of 5,10-methylenetetrahydrofolate reductase activity really should be unable to synthesize any S-adenosylmethionine beside what the betaine pathway might afford, although that probably wouldn't be operative as well, so they really should have no methylation present. Have you had a chance to study that? Dr. Waterland: Don't disregard the betaine-homeocysteine methyltransferase pathway; that can compensate for a methionine synthase deficiency and provide a fungible source of methyl donors.
Dr. Berry: I was actually interested in that as well. It is not clear why the betaine pathway exists in the first place. Is it more important developmentally than in postnatal life when the more traditional methionine pathway would take over?
Dr. Waterland: I don't know if it is possible to say which is more important but I think it is a good example of the redundancy that is built into many of these critical pathways. To address your original question, I don't know of any genome-wide studies looking at methylation changes in individuals with inborn errors; that would be very interesting. What is also interesting is that when people look at global methylation, just taking overall 5-methylcytosine content of the genome in situations where we would expect to see a profound hypomethylation, in several cases just the opposite has been reported. So there appears to be not only redundancy but also compensatory mechanisms that kick in and can lead to counter-intuitive effects.
Dr. Berry: With regard to prenatal methylation, is this a binary process or more of a continuous one? In other words if a methyltransferase is destined to methylate a particular area of DNA, does it or doesn't it happen, or does it happen sometimes in a partial way? For instance, if you need more than one cytosine moiety in an area that can bind to a transcription factor, do they all get methylated to do the job or does it happen where maybe only one or two of a group of four that will necessarily get methylated?
Dr. Waterland: It depends on the specific genomic region you are talking about. For the last decade or so a great deal of attention has been focused on CpG islands, which are CG-rich areas that are often found in the promoter regions of genes. In most cases at CpG islands, you get the kind of all or nothing methylation pattern you are talking about, either you get hypermethylation and silencing or you don't. But increasingly we are finding that also methylation at CpG sites not within CpG islands can also be critical, even at single sites such as found by Weaver et al. [2] . There are other examples where methylation at a single CG site, for example within an intron of a gene, is correlated with expression of that gene.
Dr. Björkstén: I have a philosophical question. We always learned that Darwin was 100% right and Lamarck was 100% wrong. As I understand epigenetics this is not quite the case and this is really a paradigm shift. Lysenko's research in the Soviet Union used to be ridiculed. Today it seems to make slightly more sense based on what we have learned on epigenetics.
Dr. Waterland: I will take your question as an opportunity to comment on Lamarckianism. For anybody who is not familiar with that, the idea is that environmentally induced adaptations can be inherited from one generation to the next. Of course, epigenetic inheritance provides a potential mechanism by which that could occur. We have shown in our studies that the environment in one generation can alter epigenotype; if that information can be conveyed to subsequent generations then you have a mechanism for this adaptive evolution that Lamarck proposed. We actually tested for that type of transgenerational epigenetic inheritance recently [4] . In the A vy model we expected that the effects of diet on epigenetic regulation of A vy would be inherited from one generation to the next and would provide a proof of principle for inheritance of acquired traits. But actually we found that the diet-induced changes at A vy were not inherited. So in the A vy mouse at least, it appears that the germline is protected from environmentally induced changes being transmitted from one generation to the next. But I do agree that this whole area opens up a potential paradigm shift in biology and it might turn out that Lamarck was just a little bit right after all.
Dr. Gluckman: Lamarck is not what we are talking about here. Lamarck was talking about the evolution of acquired characteristics. What Dr. Waterland is showing is inheritance to the environmental memory; the echo of the environment of one generation being transmitted to another. I think it was very unfortunate that Eva Jablonka, who is really the mother of this field in many ways, called her book Neo-Lamarckism and I think it has caused a delay in the understanding of the biology that is involved here. In terms of Lysenko, there is actually a recent paper showing that vernalization does lead to epigenetic changes in some of the genes in maize or corn. Of course that is not really what Lysenko was really doing; he was doing other things which were much more horrible.
Dr. Lau: Some people define the epigenetic code to include more than just DNA methylation, including the histone methylation pattern, etc. How tightly are those two processes co-regulated and, if so, are we missing something if we only look at the DNA methylation pattern?
Dr. Waterland: Epigenetics is not just about DNA methylation. Additional mechanisms including numerous modifications to the histone proteins and various autoregulatory DNA-binding proteins participate in maintaining the overall epigenetic state of a genomic region. Many people would add micro-RNAs to this list of mechanisms because in plants there are a lot of good data indicating a role for micro-RNAs, but that remains unclear in mammals. I certainly don't mean to imply that DNA methylation is the only thing that is important, but what is really nice about DNA methylation is that it is relatively simple to measure; on each allele, a specific CG site is either methylated or it is not. For histone modifications, on the other hand, while it is proposed that there is a histone code, the list of participating modifications just becomes longer and longer every year and the correspondence between a given modification and transcriptional activity becomes less and less clear. Another great advantage of studyIndividual Epigenetic Variation: When, Why, and So What? ing DNA methylation is that of all the epigenetic mechanisms it is the most stable, so it has the potential to act as a persistent mechanism that might be able to transduce a memory all the way from infancy or embryonic development into adulthood, unlike histone modifications which are relatively dynamic.
Dr. Adlerberth: Could it be possible that contact with microbes or infectious diseases may have some influence on methylation patterns? Dr. Waterland: Yes certainly, from almost any perspective imaginable there are interesting questions in developmental biology that now can be viewed from this molecular epigenetic perspective. In fact I have a GI fellow, Richard Kellermayer, who is very interested in exploring the role of epigenetic mechanisms in gut development. He is currently working on characterizing the ontogeny of these processes and examining what types of environmental stimuli during critical periods of development might affect epigenetic outcomes relevant to GI pathology. Just perhaps a closing comment, it is interesting that even though Lamarck is most known for the inheritance of acquired traits, which is his fourth evolutionary law, his first evolutionary law may actually be most relevant today. It says that, 'Life by its own forces tends continually to increase the volume of every body that proposes it, as well as to increase the size of all parts of the body up to a limit which it imposes upon itself'. In the context of the worldwide obesity epidemic, I would say that Lamarck's first law is strikingly prescient.
Dr. Walker: Just to come back to your comment, microbes can ferment undigested oligosaccharides causing short-chain fatty acids to be produced. One fatty acid, butyrate, is thought to cause histone deacetylation which may be a transient phenomenon. This may not be similar to epigenetic changes but I think there may be some associations.
Dr. Waterland: Certainly the histone deacetylase inhibition caused by butyric acid in the gut could lead to changes in transcription and then lead to a more stabilized epigenetic state at a given locus. So yes, the intersection of all these different mechanisms is going to need to be considered.
Dr. Hernell: You talked about those windows and that there is a critical postnatal period, but how long could that period actually be? In the twin studies you also showed that differences can be found later. We know that mutations increase in elderly people. Would it be possible that there is an increase in epigenetic effects in elderly people?
Dr. Waterland: Yes, certainly the aging process is another source of epigenetic variation and the most classic study of that is from Issa et al. [5] back in the 1990s. They showed that the estrogen receptor gene promoter in the colon shows a very nice progression of hypermethylation with age. Hypermethylation of this gene appears to play a role in colon tumorigenesis. So yes, you are correct, aging is certainly another very important factor relating to epigenetic variation and disease.
Dr. Corsello: What is your opinion on the risk of epigenetic variation and abnormalities during assisted reproductive technologies (ARTs), and do you think it should be predicted?
Dr. Waterland: Yes, that is a very important question right now. Increasingly, epidemiological studies are showing that there is a higher incidence of several epigenetically based developmental diseases such as Beckwith-Wiedemann syndrome in individuals who have been conceived by ARTs [6] . These types of outcomes are consistent with studies that have shown that culturing the early embryo in vitro leads to persistent epigenetic changes. So essentially we have underway a huge human experiment on the long-tern effects of ARTs and, alarmingly, these technologies are becoming increasingly popular. While many people say that everything is fine, that obviously there is no big problem, one has to consider that the oldest individual who was con-ceived by ARTs is only about 30 years old. It is quite possible that these relatively rare early developmental syndromes are only the tip of an iceberg. When these individuals are in their 50s and 60s, we don't know what might happen as far as susceptibility to cancer and other diseases related to epigenetic dysregulation is concerned.
